(Q36623410)

15 August 2017

Malaria vaccine development: current status (English)

1 reference

15 August 2017

0 references

1 reference

Engers HD

1

1 reference

PubMed ID

17040699

15 August 2017

Godal T

series ordinal

2

1 reference

15 August 2017

1 February 1998

1 reference

15 August 2017

Trends in Parasitology

1 reference

15 August 2017

14

1 reference

15 August 2017

2

1 reference

15 August 2017

56-64

1 reference

Potential impact of global climate change on malaria risk

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Malaria--a neglected disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

The need for assays predictive of protection in development of malaria bloodstage vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Immunization of man against sporozite-induced falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Human malaria parasites in continuous culture

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Cultivation of fertile Plasmodium falciparum gametocytes in semi-automated systems. 1. Static cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Efficient isolation of genes by using antibody probes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Antibody and clinical responses in volunteers to immunization with malaria peptide-diptheria toxoid conjugates.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Immunogenicity of an alum-adsorbed synthetic multiple-antigen peptide based on B- and T-cell epitopes of the Plasmodium falciparum CS protein: possible vaccine application.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Multi-gene vaccination against malaria: A multistage, multi-immune response approach

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Use of novel adjuvants and delivery systems to improve the humoral and cellular immune response to malaria vaccine candidate antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Safety, immunogenicity and limited efficacy study of a recombinant Plasmodium falciparum circumsporozoite vaccine in Thai soldiers.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Approaches to Augmenting the Immunogenicity of Melanoma Gangliosides: From Whole Melanoma Cells to Ganglioside‐KLH Conjugate Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Mice immunized with a synthetic peptide construct corresponding to an epitope present on a Plasmodium falciparum antigen are protected against Plasmodium chabaudi challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Induction of protective immunity against experimental infection with malaria using synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Efficacy trial of malaria vaccine SPf66 in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901184-8

7 January 2021

10.1016/S0169-4758(97)01184-8

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17040699